PRAX
PRAX
NASDAQ · Biotechnology

Praxis Precision Medicines I

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$308.94
+3.57 (+1.17%)
As of Jun 24, 9:47 PM ET ·
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 20 87%
Hold 2 9%
Sell 1 4%
Price Target
Analyst Price Target -93.7% upside
Low Target $15.93
Average Target $19.45
High Target $25.00
Current Price $308.94
Current
$308.94
Target
$19.45
$15.93 $19.45 avg $25.00
Scenario Analysis
Bear Case
$15.93
-94.8%
Low target
Base Case
$19.45
-93.7%
Avg target
Bull Case
$25.00
+-91.9%
High target
Risk/Reward
1.0x
Unfavorable
Price in Context
52-Week High
$366.52
-15.7% from high
52-Week Low
$37.19
+730.7% from low
50-Day SMA
$296.27
+4.3% vs SMA
200-Day SMA
$133.67
+131.1% vs SMA
RSI (14)
61.8
Neutral
Target vs 52W High
$19.45
-94.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%